CN103110766A - Traditional Chinese medical composition for treating postpartum urinary retention - Google Patents
Traditional Chinese medical composition for treating postpartum urinary retention Download PDFInfo
- Publication number
- CN103110766A CN103110766A CN2013100944193A CN201310094419A CN103110766A CN 103110766 A CN103110766 A CN 103110766A CN 2013100944193 A CN2013100944193 A CN 2013100944193A CN 201310094419 A CN201310094419 A CN 201310094419A CN 103110766 A CN103110766 A CN 103110766A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- traditional chinese
- chinese medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medical composition for treating postpartum urinary retention. The traditional Chinese medical composition for treating postpartum urinary retention consists of astragalus mongholicus, angelica sinensis, codonopsis pilosula, poria cocos, fried rhizoma atractylodis macrocephalae, rhizoma alismatis, cassia twig, fructus psoraleae, rattletop, radix bupleuri, almond, ligusticum wallichii, flowers carthami and honey-fried licorice root by certain weigh percent. The traditional Chinese medical composition has the function of tonifying middle-Jiao and Qi, eliminating dampness and diuresis and clearing heat and dispersing blood stasis, and can be effectively used for treating postpartum urinary retention.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for postpartum retention of urine.
Background technology
Postpartum retention of urine refers to a large amount of urines of 6～8h bladder retention and can not discharging in puerperal, and the urine meaning is urgent, and the hypogastric region distending pain unbearably, is one of common complication in puerperal.Natural labor person's urine retention incidence rate approximately 14%, operation practise midwifery person incidence rate is up to 26%～38%, untimely processing not only affects genitals's in puerperal restoration of old ways, also can cause urinary system infection, increase the puerperal infection chance, even develop into chronic urinary retention, urinary incontinence and hydronephrosis and renal insufficiency etc.Postpartum retention of urine belongs to Chinese medicine " difficulty in urination " category.Sick position is at kidney and bladder, and relevant with lung, spleen, liver, stomach, the deficiency of vital energy be this, and water liquid stops poly-for marking.Its occurrence cause is that antenatal insufficiency of vital energy and blood or plain body are weak, the consumption gas of losing blood during more because of product, and punching is appointed not enough, so that water liquid gathers in bladder and falls ill.Doctor trained in Western medicine there is no specific short except urethral catheterization (indwelling catheter easily merges urinary system infection).The traditional Chinese medical science is obvious to the postpartum retention of urine therapeutic effect, uses safety, has no side effect, and puerpera's no pain is easily accepted by the puerpera.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition, this Chinese medicine composition has evident in efficacy for postpartum retention of urine, rapid-action, the characteristics that have no side effect.
The present invention selects the Radix Astragali, Radix Angelicae Sinensis, Radix Codonopsis, Poria, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Alismatis, Ramulus Cinnamomi, Fructus Psoraleae, Rhizoma Cimicifugae, Radix Bupleuri, Semen Armeniacae Amarum, Rhizoma Chuanxiong, Flos Carthami, Radix Glycyrrhizae Preparata to make up, make each efficacy of drugs produce synergism these drug regimens, make it to have invigorating the spleen and replenishing QI, eliminating dampness and diuresis, the effect of heat clearing and blood stasis dispersing, thus can be effective to postpartum retention of urine.
The effect of Chinese medicine of the present invention:
Wherein:
The Radix Astragali: be the root of leguminous herbaceous plant's Radix Astagali, Radix Astragali.Nature and flavor are sweet, tepor.Return lung, spleen, liver, kidney channel.Effect: benefiting QI for strengthening the superficies, arresting sweating take off, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema admittedly.The Radix Astragali has medium diuresis.
Radix Angelicae Sinensis: be the dry root of umbelliferae angelica Angelica sinensis (Oliv.) Diels.Nature and flavor are sweet, hot, bitter, temperature.Return liver, the heart, spleen channel.Effect: enrich blood; Invigorate blood circulation; Menstruction regulating and pain relieving; Moisturize laxation.
Radix Codonopsis: be the dry root of Campanulaceae Radix Codonopsis Codonopsis pilosula (Franch.) Nannf., element flower Radix Codonopsis Codonopsis pilosula Nannf.var. modesta (Nannf.) L. T. Shen or radix codonpsis tangshen Codonopsis tangshen Oliv..Nature and flavor are flat, sweet, little acid.Return spleen, lung meridian.Effect: invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.
Poria: be the dry sclerotia of On Polyporaceae Poria Poria cocos (Schw.) Wolf.Nature and flavor are sweet, light, and are flat.GUIXIN, lung, spleen, kidney channel.Effect: eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming.Poria has diuresis, and aspect the diuretic effect, compound recipe can produce continuous action than single medicinal material.
Rhizoma Atractylodis Macrocephalae (parched): be the dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae Atractylodes macrocephala Koidz..Nature and flavor are bitter, sweet, temperature.Return spleen, stomach warp.Effect: invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis.Has obvious and lasting diuresis.Tang Materia Medica: diuresis.
Rhizoma Alismatis: be the dry tuber of Notes On Alism At Aceae Rhizoma Alismatis Alisma orientalis (Sam.) Juzep..Nature and flavor are sweet, and are light, cold.Return kidney, urinary bladder channel.Effect: promoting diuresis to eliminate damp pathogen; Expel the heat-evil treating stranguria.Rhizoma Alismatis has diuresis." medicineization justice ": all genus rush down disease, and little water must short number, with this (Rhizoma Alismatis) clear and rich lung qi, and regulating fluid apssage, lower defeated bladder cures mainly the watery diarrhea dairrhea caused by pathogenic damp, makes and defecates real, and temper is from being good for also.Because of the energy dredging water passages, make evil water go, true water must be supported, and can stop therefore quench one's thirst.Again can be except damp and hot, treating stranguria drop divides the feeling of fullness that disappears, and the three warmers accumulation of heat is cut off the water thoroughly, and this is diuretic the first non-defective unit." book on Chinese herbal medicine justice ": Rhizoma Alismatis, the kind sluice way that oozes, the urine of specially passing through.
Ramulus Cinnamomi: be the dry twig of canella Cortex Cinnamomi Cinnamomum cassia Presl.Nature and flavor are hot, sweet, temperature.Enter bladder, the heart, lung meridian.Effect: diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain.Ramulus Cinnamomi has diuresis.
Fructus Psoraleae: be the dry mature fruit of legumes psoraleae Psoralea corylifolia L..Nature and flavor are hot, bitter, temperature.Return kidney, pericardium, spleen, stomach, lung meridian.Effect: reinforcing the kidney and supporting YANG; Helping inspiration to relieve asthma; Warming spleen and stopping diarrha.
Rhizoma Cimicifugae: be the dry rhizome of ranunculaceae plant C.heracleifolia Cimicifuga heracleifolia Kom., Cimicifuga Dahurica Cimicifuga dahurica (Turcz.) Maxim. or Rhizoma Cimicifugae Cimicifuga foetida L..Nature and flavor are hot, little sweet, are slightly cold.Return lung, spleen, stomach, large intestine channel.Effect: deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.Furan chromone derivant kairine (Khellin) has obvious spasmolysis to smooth muscle (bladder, uterus etc.), and the furan chromone class is the main active of Rattleroot rhizome.
Radix Bupleuri: be dry root or the herb of umbelliferae bupleurum or Radix Bupeuri Scorzonerfolii..Nature and flavor are slightly cold, hardship, suffering.Return liver, lung, spleen channel.Effect: expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
Semen Armeniacae Amarum: be the dry mature seed of .var.ansu (Maxim.) Yu et Lu., Siberia Fructus Pruni Armeniaca sibirica (L.) Lam., prunus mandshuricaKoehne Armeniaca mandshurica (Maxim.) Skv. or Fructus Pruni Armeniaca vulgaris Lam..Nature and flavor are bitter, tepor; Slightly poisonous.Return lung meridian.Effect: relieving cough and asthma, loosening bowel to relieve constipation.
Rhizoma Chuanxiong: be the dry rhizome of samphire Rhizoma Chuanxiong Ligusticum chuanxiong Hort..Nature and flavor are hot, temperature.Return liver, gallbladder, pericardium channel.Effect: blood circulation promoting and blood stasis dispelling; Activating QI to alleviate the depression; Wind-expelling pain-stopping.Ligustrazine can diuresis.
Flos Carthami: be the tubular corolla of feverfew Flos Carthami Carthamus tinctorius L..Nature and flavor are hot, warm.GUIXIN, Liver Channel.Effect: promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.
Radix Glycyrrhizae Preparata: be the dry root and rhizome of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..Radix Glycyrrhizae Preparata is that the honey of Radix Glycyrrhizae is smoked processed goods.Nature and flavor are sweet, and are flat.GUIXIN, lung, spleen, stomach warp.Effect: spleen reinforcing stomach function regulating, Yiqi and vein recovery.
Medicine material consumption of the present invention is groped to sum up to draw through the inventor in a large number, and each raw material consumption is for all to have curative effect preferably in the following weight parts scope: Radix Astragali 45-55 part, Radix Angelicae Sinensis 15-25 part, Radix Codonopsis 15-25 part, Poria 15-25 part, Rhizoma Atractylodis Macrocephalae (parched) 25-35 part, Rhizoma Alismatis 13-23 part, Ramulus Cinnamomi 15-25 part, Fructus Psoraleae 15-25 part, Rhizoma Cimicifugae 15-25 part, Radix Bupleuri 6-12 part, Semen Armeniacae Amarum 5-15 part, Rhizoma Chuanxiong 10-20 part, Flos Carthami 6-12 part, Radix Glycyrrhizae Preparata 5-15 part.
Wherein be preferably: 50 parts of the Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts, Poria, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 18 parts of Rhizoma Alismatis, 20 parts of Ramulus Cinnamomi, 20 parts of Fructus Psoraleaes, 20 parts of Rhizoma Cimicifugaes, 9 parts of Radix Bupleuri, 10 parts, Semen Armeniacae Amarum, 15 parts of Rhizoma Chuanxiongs, 9 parts, Flos Carthami, 10 parts of Radix Glycyrrhizae Preparatas.
Medicine pulverization of the present invention, mix homogeneously is prepared into powder, adds appropriate vinegar and fries altogether, cloth bag, hot compress lower abdomen 30 minutes.
Medicine of the present invention has invigorating the spleen and replenishing QI, eliminating dampness and diuresis, and effects such as heat clearing and blood stasis dispersing, and evident in efficacy, rapid-action have no side effect, and according to clinical 100 routine patients are observed statistics, use 85%, two of one of the medicine of the present invention total effective rate course for the treatment of total effective rate course for the treatment of 98%.
The specific embodiment
Embodiment one, 45 parts of the Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 15 parts, Poria, 25 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 13 parts of Rhizoma Alismatis, 15 parts of Ramulus Cinnamomi, 15 parts of Fructus Psoraleaes, 15 parts of Rhizoma Cimicifugaes, 6 parts of Radix Bupleuri, 5 parts, Semen Armeniacae Amarum, 10 parts of Rhizoma Chuanxiongs, 6 parts, Flos Carthami, 5 parts of Radix Glycyrrhizae Preparatas.
Embodiment two, 50 parts of the Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts, Poria, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 18 parts of Rhizoma Alismatis, 20 parts of Ramulus Cinnamomi, 20 parts of Fructus Psoraleaes, 20 parts of Rhizoma Cimicifugaes, 9 parts of Radix Bupleuri, 10 parts, Semen Armeniacae Amarum, 15 parts of Rhizoma Chuanxiongs, 9 parts, Flos Carthami, 10 parts of Radix Glycyrrhizae Preparatas.
Embodiment three, 55 parts of the Radixs Astragali, 25 parts of Radix Angelicae Sinensis, 25 parts of Radix Codonopsis, 25 parts, Poria, 35 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 23 parts of Rhizoma Alismatis, 25 parts of Ramulus Cinnamomi, 25 parts of Fructus Psoraleaes, 25 parts of Rhizoma Cimicifugaes, 12 parts of Radix Bupleuri, 15 parts, Semen Armeniacae Amarum, 20 parts of Rhizoma Chuanxiongs, 12 parts, Flos Carthami, 15 parts of Radix Glycyrrhizae Preparatas.
The below is the clinical statistics data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 100 examples for medical treatment, 30 years old mean age.
Two, diagnostic criteria:
1, between puerperal, the urine drop is and lower or inaccessible obstructed, and anxious pain that lower abdomen is swollen often has prolonged labor and operation to produce history.
2, hypogastric region bulge, filling of bladder has tenderness.
3, routine urinalysis is without extremely.
Three, using method
According to drug weight proportioning of the present invention, weighting raw materials (dose), every day twice, respectively once, 10 is a course for the treatment of sooner or later.
Four, efficacy assessment standard
1, cure: urine is unobstructed, and symptom, sign disappear.
2, effective: urine is substantially unobstructed, and symptom, sign are clearly better.
3, invalid: after treatment finished, symptom, sign were without improvement.
Five, therapeutic outcome statistics
Wherein: total effective rate=cure rate+effective percentage
Model case and curative effect:
Case one, Zheng, 24 years old age.Produce and to fail one day after voluntary micturition, lower distention and fullness in the abdomen is felt bad, uneasy in either sitting or lying.The patient adopts herbal fomentation lower abdomen of the present invention after course for the treatment of, and urine is unobstructed, and transference cure is cured.
Case two, Chen, at 33 years old age, puerperal is urinary obstruction always, lower abdomen distension hurt like hell, waist acid is swollen, pale complexion, spiritlessness and weakness, pale tongue with white fur, deep-slow pulse.The patient adopts herbal fomentation lower abdomen of the present invention after two courses for the treatment of, and urine is unobstructed, and transference cure is cured.
Case three, Wu, at 28 years old age, can not urinate two days puerperal always, urinary obstruction, it is anxious and pain is afraid of cold that lower abdomen is swollen, soreness of the waist and knees, the whole body is weak, and pale tongue with thin fur is white, deep-thready pulse and late.The patient adopts herbal fomentation lower abdomen of the present invention after two courses for the treatment of, and urine is substantially unobstructed, and symptom is clearly better.
Claims (2)
1. Chinese medicine composition that is used for postpartum retention of urine, it is characterized in that, this Chinese medicine composition is the ingredients by following weight portion: Radix Astragali 45-55 part, Radix Angelicae Sinensis 15-25 part, Radix Codonopsis 15-25 part, Poria 15-25 part, Rhizoma Atractylodis Macrocephalae (parched) 25-35 part, Rhizoma Alismatis 13-23 part, Ramulus Cinnamomi 15-25 part, Fructus Psoraleae 15-25 part, Rhizoma Cimicifugae 15-25 part, Radix Bupleuri 6-12 part, Semen Armeniacae Amarum 5-15 part, Rhizoma Chuanxiong 10-20 part, Flos Carthami 6-12 part, Radix Glycyrrhizae Preparata 5-15 part.
2. Chinese medicine composition for postpartum retention of urine described according to claims 1, it is characterized in that, by the ingredients of following weight portion: 50 parts of the Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts, Poria, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 18 parts of Rhizoma Alismatis, 20 parts of Ramulus Cinnamomi, 20 parts of Fructus Psoraleaes, 20 parts of Rhizoma Cimicifugaes, 9 parts of Radix Bupleuri, 10 parts, Semen Armeniacae Amarum, 15 parts of Rhizoma Chuanxiongs, 9 parts, Flos Carthami, 10 parts of Radix Glycyrrhizae Preparatas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100944193A CN103110766A (en) | 2013-03-23 | 2013-03-23 | Traditional Chinese medical composition for treating postpartum urinary retention |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100944193A CN103110766A (en) | 2013-03-23 | 2013-03-23 | Traditional Chinese medical composition for treating postpartum urinary retention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103110766A true CN103110766A (en) | 2013-05-22 |
Family
ID=48409171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100944193A Pending CN103110766A (en) | 2013-03-23 | 2013-03-23 | Traditional Chinese medical composition for treating postpartum urinary retention |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110766A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550465A (en) * | 2013-10-29 | 2014-02-05 | 任英霞 | Preparation method of drug composition for treating postcesarean urinary retention |
| CN103735824A (en) * | 2013-12-14 | 2014-04-23 | 郑明立 | Drug for treating postpartum uroschesis and preparation method thereof |
| CN103830697A (en) * | 2014-02-28 | 2014-06-04 | 崔新明 | Medicament composition for treating postpartum uroschesis |
| CN104027774A (en) * | 2014-06-17 | 2014-09-10 | 徐艳卿 | Traditional Chinese medicine composition capable of treating uroschesis |
| CN104055985A (en) * | 2014-04-03 | 2014-09-24 | 姜宏志 | Externally-applied medicine for treating anorectal postoperative urinary retention |
| CN104367730A (en) * | 2014-11-13 | 2015-02-25 | 廖福存 | Medicine for treating postpartum urinary retention |
| CN104435946A (en) * | 2014-11-27 | 2015-03-25 | 李善臻 | External application traditional Chinese medicine agent and nursing method for treating postpartum urinary retention |
| CN104491425A (en) * | 2014-11-27 | 2015-04-08 | 韩海霞 | Traditional Chinese medicine fumigant for treating postpartum urinary retention and nursing method for postpartum urinary retention |
| CN105267785A (en) * | 2015-11-30 | 2016-01-27 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation used for treating postpartum urinary retention |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060073708A (en) * | 2004-11-17 | 2006-06-29 | 최양원 | Manufacturing method of a herb medicine for atopic skin diseases |
| CN101152367A (en) * | 2007-09-17 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating pregnancy urinary retention |
| CN101804169A (en) * | 2010-05-28 | 2010-08-18 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating urinary incontinence and preparation method thereof |
| KR20120022134A (en) * | 2010-09-01 | 2012-03-12 | 권오진 | The food with overcome fatigue , using herbs |
| CN102552857A (en) * | 2012-02-13 | 2012-07-11 | 李承平 | Capsule for removing blood stasis for promoting tissue regeneration after childbirth |
| CN102836225A (en) * | 2011-06-23 | 2012-12-26 | 王东 | Traditional Chinese drug preparation for treating postpartum urine retention |
-
2013
- 2013-03-23 CN CN2013100944193A patent/CN103110766A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060073708A (en) * | 2004-11-17 | 2006-06-29 | 최양원 | Manufacturing method of a herb medicine for atopic skin diseases |
| CN101152367A (en) * | 2007-09-17 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating pregnancy urinary retention |
| CN101804169A (en) * | 2010-05-28 | 2010-08-18 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating urinary incontinence and preparation method thereof |
| KR20120022134A (en) * | 2010-09-01 | 2012-03-12 | 권오진 | The food with overcome fatigue , using herbs |
| CN102836225A (en) * | 2011-06-23 | 2012-12-26 | 王东 | Traditional Chinese drug preparation for treating postpartum urine retention |
| CN102552857A (en) * | 2012-02-13 | 2012-07-11 | 李承平 | Capsule for removing blood stasis for promoting tissue regeneration after childbirth |
Non-Patent Citations (2)
| Title |
|---|
| 于释然: "《中华良方验方大全》", 31 January 2006, article "补中益气汤合五苓散加减治产后尿潴留", pages: 311 * |
| 陈立怀: "《中华良方验方大全》", 31 January 2006, 科学技术文献出版社 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550465A (en) * | 2013-10-29 | 2014-02-05 | 任英霞 | Preparation method of drug composition for treating postcesarean urinary retention |
| CN103550465B (en) * | 2013-10-29 | 2015-08-19 | 任英霞 | A kind of preparation method for the treatment of the pharmaceutical composition of cesarean postpartum urinary retention |
| CN103735824A (en) * | 2013-12-14 | 2014-04-23 | 郑明立 | Drug for treating postpartum uroschesis and preparation method thereof |
| CN103830697A (en) * | 2014-02-28 | 2014-06-04 | 崔新明 | Medicament composition for treating postpartum uroschesis |
| CN104055985A (en) * | 2014-04-03 | 2014-09-24 | 姜宏志 | Externally-applied medicine for treating anorectal postoperative urinary retention |
| CN104027774A (en) * | 2014-06-17 | 2014-09-10 | 徐艳卿 | Traditional Chinese medicine composition capable of treating uroschesis |
| CN104367730A (en) * | 2014-11-13 | 2015-02-25 | 廖福存 | Medicine for treating postpartum urinary retention |
| CN104435946A (en) * | 2014-11-27 | 2015-03-25 | 李善臻 | External application traditional Chinese medicine agent and nursing method for treating postpartum urinary retention |
| CN104491425A (en) * | 2014-11-27 | 2015-04-08 | 韩海霞 | Traditional Chinese medicine fumigant for treating postpartum urinary retention and nursing method for postpartum urinary retention |
| CN105267785A (en) * | 2015-11-30 | 2016-01-27 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation used for treating postpartum urinary retention |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110766A (en) | Traditional Chinese medical composition for treating postpartum urinary retention | |
| CN102872418B (en) | Medicine for treating pelvic inflammation | |
| CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN104352776A (en) | Traditional Chinese medicine preparation for treating infertility caused by hypomenorrhea and preparation method thereof | |
| CN104383115A (en) | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation | |
| CN101862428A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN104758852A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
| CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
| CN103071028A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura | |
| CN103041262B (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
| CN102600426A (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
| CN104721644A (en) | Traditional Chinese medicine preparation for knee osteoarthritis and preparation method of traditional Chinese medicine preparation | |
| CN102940716A (en) | Traditional Chinese medicine for treatment of uterine prolapse | |
| CN102805825B (en) | Drug for curing cutaneous pruritus and preparation method thereof | |
| CN104689252A (en) | Traditional Chinese preparation for treating Wegener granulomatosis and preparation method thereof | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof | |
| CN104740332A (en) | Traditional Chinese medicine used for treating erythema nodosum | |
| CN103705684A (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN103610893A (en) | Traditional Chinese medicine for treating coronary disease | |
| CN103263611A (en) | Traditional Chinese medicine composition for treating colonitis | |
| CN104906497A (en) | Traditional Chinese medicine preparation for treating eosinophilic fasciitis and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130522 |